Dataset from Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

The aim of the study is to describe the immunogenicity and safety of the new formulation of Quadrivalent Influenza Vaccine (QIV) for the 2013-2014 season in the Northern Hemisphere (NH) in subjects aged 9 to 17 years in Taiwan Primary Objective: - To describe the immunogenicity of the QIV (split-virion, inactivated) NH seasonal formulation Secondary Objective: - To describe the safety of the QIV (split-virion, inactivated) NH seasonal formulation